All In Biotech

Drug Trial Radar · NCT05027906

Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant

A Phase 1b, Multicenter, Open Label Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant

Last checked: Nov 19, 2026Latest source record: Jun 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

48

Planned (sponsor's estimate)

Start

Feb 18, 2022

Primary completion

Jan 2027

Study completion Jan 2027

Sponsor

Lead sponsor
Eledon PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Aug 30, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the safety, PK, and efficacy of AT 1501 in patients undergoing kidney transplantation.

Conditions

  • Prevention of Rejection in Kidney Transplant

Interventions

  • AT-1501Drug

    Investigative Arm

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety IncidencesTime frame: Through study completion, an average up to 20 months
  2. Pharmacokinetic- PK profileTime frame: Day 1 and at steady state Month 3
  3. Pharmacokinetic- Area under the plasma concentrationTime frame: Day 1 and at steady state Month 3
  4. Pharmacokinetic- CmaxTime frame: Day 1 and at steady state Month 3
  5. Pharmacokinetic- TmaxTime frame: Day 1 and at steady state Month 3
  6. Pharmacokinetic- KeTime frame: Day 1 and at steady state Month 3
  7. Pharmacokinetic- (t1/2)Time frame: Day 1 and at steady state Month 3
  8. Pharmacokinetic- CLTime frame: Day 1 and at steady state Month 3
  9. Pharmacokinetic- (Vdss)Time frame: Day 1 and at steady state Month 3

Locations

9 sites in 5 countries. Site status is shown where the registry gives one.

  • University of Cincinnati

    Cincinnati, Ohio · Recruiting

  • Royal Prince Alfred Hospital

    Camperdown, New South Wales, Australia · Recruiting

  • Royal Adelaide Hospital

    Adelaide, South Australia, Australia · Recruiting

  • Fundação Oswaldo Ramos - Hospital do Rim

    São Paulo, Brazil · Recruiting

  • Providence Health Care - St. Paul's Hospital

    Vancouver, British Columbia, Canada · Recruiting

  • Vancouver General Hospital

    Vancouver, British Columbia, Canada · Recruiting

  • McGill University Health Care Centre

    Montreal, Quebec, Canada · Recruiting

  • Liverpool University Hospitals NHS Foundation Trust - Royal Liverpool University Hospital

    Liverpool, United Kingdom · Recruiting

  • Oxford University Hospitals NHS Foundation Trust - John Radcliffe Hospital

    Oxford, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.